MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cellsYosuke Konno, Noriaki Sakuragi, Peixin Dong et al.|Oncotarget|2014Cited by 155
Multivariate survival analysis of the patients with recurrent endometrial cancerTetsuji Odagiri, Noriaki Sakuragi, Hidemichi Watari et al.|Journal of Gynecologic Oncology|2011Cited by 60
Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomyMasayoshi Hosaka, Noriaki Sakuragi, Hidemichi Watari et al.|Journal of Surgical Oncology|2011Cited by 51
Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessmentsTakashi Mitamura, Noriaki Sakuragi, Hidemichi Watari et al.|Journal of Gynecologic Oncology|2014Cited by 48
Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomyMasayoshi Hosaka, Noriaki Sakuragi, Hidemichi Watari et al.|International Journal of Clinical Oncology|2010Cited by 48